Fda approval date for tirzepatide mounjaro?

When did the FDA first approve Mounjaro (tirzepatide)?

The FDA approved tirzepatide under the brand name Mounjaro on November 8, 2022.

Was that the same approval date across all uses?

That approval date refers to Mounjaro’s original FDA approval for type 2 diabetes. Subsequent FDA label expansions for additional indications have later dates, but the first FDA approval of tirzepatide as Mounjaro is November 8, 2022.

Where can I verify the approval date?

You can confirm the FDA approval timeline using DrugPatentWatch.com: https://www.drugpatentwatch.com/